Key facts
- It has raised $4.5M across 5 recorded rounds; the latest was Seed Round ($600K) in Mar 2026.
- Notable investors include Johns Hopkins Technology Ventures.
- Iyuda Therapeutics has filed 5 Form Ds with the SEC since 2023, most recently Jun 2025 ($1.3M sold to 3 investors).
- Status: Privately Held (backing).
Investors
1Free account
See the evidence behind this price
- ·Post-money valuations for all 5 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Iyuda Therapeutics
Create free account
No card required
Funding rounds
5 roundsAbout Iyuda Therapeutics
The company is currently operating in Stealth Mode.
- Sector
- Healthcare
- HQ
- Owings Mills, MD, United States
- Founded
- 2007
- Website
- iyuda.com/
- Ownership
- Privately Held (backing)
PA Mark — not yet priced
Iyuda Therapeutics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Pro members can request priority coverage with a 48-hour turnaround.
Recorded secondary trades
No prints on record
No secondary trades in Iyuda Therapeutics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Pro members can request priority coverage with a 48-hour turnaround.
Institutional fund marks
No fund marks yet
No SEC-registered fund has reported a fair-value mark on Iyuda Therapeutics in its N-PORT filings yet. We sweep new filings monthly.
Pro members can request priority coverage with a 48-hour turnaround.